Global Imfinzi Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Imfinzi Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
IMFINZI® (durvalumab) is an immunotherapy used to treat patients with urothelial carcinoma, a type of bladder cancer
Imfinzi report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Imfinzi market is projected to reach US$ 5734.7 million in 2029, increasing from US$ 2784 million in 2022, with the CAGR of 10.2% during the period of 2024 to 2029. Demand from Retail Pharmacy and Hospital Pharmacy are the major drivers for the industry.
The PD-1 and PD-L1 Inhibitor market is driven by the increasing demand for advanced immunotherapy options in oncology. PD-1 and PD-L1 inhibitors are revolutionary treatments that block specific proteins, enhancing the immune system's ability to recognize and attack cancer cells. The growing prevalence of various cancers, coupled with the need for targeted therapies that offer improved efficacy and fewer side effects compared to traditional treatments, contributes to market growth. Additionally, the expanding list of approved indications for these inhibitors, such as melanoma, lung cancer, and more, further propels adoption. However, challenges include managing potential immune-related adverse events and identifying patients who are most likely to respond to these treatments. Navigating the complex landscape of combination therapies and addressing access and affordability barriers for a broader patient population are ongoing concerns. The market's success relies on continuous research to optimize treatment regimens and identify biomarkers for patient selection, comprehensive patient education about the potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to advance cancer treatment while addressing the evolving challenges associated with PD-1 and PD-L1 inhibitor therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Imfinzi market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Segment by Type
2.4ml
10ml
Retail Pharmacy
Hospital Pharmacy
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Imfinzi market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Imfinzi, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Imfinzi industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Imfinzi in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Imfinzi introduction, etc. Imfinzi Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Imfinzi market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Imfinzi report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Imfinzi market is projected to reach US$ 5734.7 million in 2029, increasing from US$ 2784 million in 2022, with the CAGR of 10.2% during the period of 2024 to 2029. Demand from Retail Pharmacy and Hospital Pharmacy are the major drivers for the industry.
The PD-1 and PD-L1 Inhibitor market is driven by the increasing demand for advanced immunotherapy options in oncology. PD-1 and PD-L1 inhibitors are revolutionary treatments that block specific proteins, enhancing the immune system's ability to recognize and attack cancer cells. The growing prevalence of various cancers, coupled with the need for targeted therapies that offer improved efficacy and fewer side effects compared to traditional treatments, contributes to market growth. Additionally, the expanding list of approved indications for these inhibitors, such as melanoma, lung cancer, and more, further propels adoption. However, challenges include managing potential immune-related adverse events and identifying patients who are most likely to respond to these treatments. Navigating the complex landscape of combination therapies and addressing access and affordability barriers for a broader patient population are ongoing concerns. The market's success relies on continuous research to optimize treatment regimens and identify biomarkers for patient selection, comprehensive patient education about the potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to advance cancer treatment while addressing the evolving challenges associated with PD-1 and PD-L1 inhibitor therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Imfinzi market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Segment by Type
2.4ml
10ml
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Imfinzi market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Imfinzi, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Imfinzi industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Imfinzi in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Imfinzi introduction, etc. Imfinzi Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Imfinzi market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices